Assessing residents prescribing behavior in renal impairment

Size: px
Start display at page:

Download "Assessing residents prescribing behavior in renal impairment"

Transcription

1 International Journal for Quality in Health Care 2003; Volume 15, Number 3: pp /intqhc/mzg034 Assessing residents prescribing behavior in renal impairment L. SALOMON 1, S. LEVU 1, G. DERAY 2, V. LAUNAY-VACHER 2,G.BRÜCKER 1 AND P. RAVAUD 3,4 1 Public Health and 2 Nephrology Departments, Groupe Hospitalier Pitié Salpêtrière et Faculté de médecine Pitié Salpêtrière (Paris VI), Paris, 3 Epidemiology and Biostatistics Department, Hôpital Bichat et Faculté de Médecine Xavier Bichat (Paris VII), Paris and 4 Unité INSERM U444, France Abstract Objective. Although fitting orders to renal function avoids overdosage and therefore iatrogenic risk, dosage adjustment is rarely made. The objective of this study was to assess residents prescribing behavior in renal impairment, through a standardized simulated clinical setting. Method. This criterion-referenced study was carried out in a French teaching hospital. The hospital had 118 residents; 71 of them were asked to complete a questionnaire including four vignettes, simulating drug prescription in four patients with various degrees of renal impairment (16 orders). The patients had an order of gentamicin sulfate, diclofenac sodium, and amlodipine bensylate. For each drug, the resident could maintain the order, discontinue the order, or change the dosage. A fourth drug, enalapril maleate, was to be started, with three possible dosages and the possibility of not prescribing it. The reference chosen for assessment was the Vidal dictionary, which corresponds to the Physician s Desk Reference and is the French reference for prescription. Results. All the residents approached for the survey accepted the offer to complete the questionnaire. Among the 16 simulated orders, the median number of appropriate orders per resident was nine. Considering the renal function of their patients, 62% of residents wrote an inappropriate order for gentamicin, 42% wrote an inappropriate order for diclofenac, and 52% wrote an inappropriate order for enalapril. Although no adjustment to renal function was required, 28% of the residents decreased the dosage of amlodipine and ordered an underdose. Conclusion. Considering the iatrogenic risk related to the lack of dosage adjustment, attention should be drawn to increasing residents awareness of dosage adjustment in renal impairment and to providing them with better information on patients renal function. Keywords: dosage adjustment, renal impairment, residents prescribing, vignettes acute renal failure and the glomerular filtration rate falls from 100 to 10 ml/min, the serum creatinine level will not change within 24 hours, until it reflects its accumulation in the plasma. In addition, an apparently minor increase in serum creatinine can reflect a marked fall in glomerular filtration rate (Figure 1). For that reason, the estimation of glomerular filtration rate through the calculation of creatinine clearance is mandatory in every patient. Although the necessity of dosage adjustment is probably underestimated in clinical practice, few studies have con- sidered this issue in hospitalized patients and the means to improve the use of medications in renal impairment [2,3,5, 8]. Measuring the competence of physicians and the quality of their actual practice has proven to be difficult and problematic. Because they control for case mix, vignettes or written cases Dosage adjustment according to renal function decreases iatrogenic risk and irreversible renal impairment [1]. Although recommended for many drugs, these adjustments are rarely made [2,3]. According to the Leape classification, the lack of adaptation may result from lack of knowledge of the drug, including: (1) underestimation of the iatrogenic risk related to decreased drug elimination in mild renal impairment; and (2) ignorance of the medications that require a dosage adjustment in renal impairment [4 6]. It may also result from a poor estimation of the renal function of the patient. Changes in glomerular filtration rate should be estimated by the clearance of creatinine calculated using the Cockcroft and Gault formula [7]. In daily routine, glomerular filtration is determined from the measurement of serum creatinine, which has severe limitations. For example, if a patient develops Address reprint requests to L. Salomon, Unité d Evaluation, Hôpital Louis Mourier, 178 rue des Renouillers, Colombes Cedex, France. laurence.salomon@lmr.ap-hop-paris.fr International Journal for Quality in Health Care 15(3) International Society for Quality in Health Care and Oxford University Press 2003; all rights reserved 235

2 L. Salomon et al. Figure 1 Relation between serum creatinine and glomerular filtration rate (GFR). simulations allow assessment among different providers and between organizations that may care for different populations of patients under different systems of care. They have been described as a valid way of assessing quality of care [9 12]. The objective of this study was to assess residents prescribing behavior in patients with renal impairment, through a standardized simulated clinical setting using hypothetical vignettes. Methods Design and setting Questionnaire The reference chosen for assessment was the 1999 edition of the Vidal dictionary [13]. This dictionary pools the man- ufacturers summaries of product characteristics. Annually updated, it is officially distributed by the French Regulatory The questionnaire included two questions exploring the concerns of residents about dosage adjustment in renal impairment: (1) Do you consider that the need for dosage adjustment in renal impairment is a frequent problem in hospital prescription? ; and (2) From what level of serum creatinine should you check if the drugs prescribed may need dosage adjustment?. It also included four clinical vignettes (Table 1), simulating drug prescription in patients with various degrees of renal This prospective criterion-referenced survey described res- idents practice through clinical vignettes, a valid and com- prehensive method of assessing quality of care and one that is able to control adequately for case-mix variation [12]. A questionnaire was distributed in May 2000 to the residents who assumed new positions in the Hospital Pitié Salpêtrière (Assistance Publique, Hôpitaux de Paris), a 2070-bed, tertiary care teaching hospital. This hospital has all major surgical and medical activities, with 40 in-patient departments, in- cluding 114 units, and > patients hospitalized every year. The hospital receives residents in all the medical and surgical departments. impairment. These drugs had been chosen in collaboration with a nephrologist and a pharmacist as they are frequently prescribed in general practice, or are well known to need adjustment in renal impairment (such as gentamicin), such that residents from medical or surgical departments might prescribe them regularly. The data provided were patient s age, gender, weight, and serum creatinine level. Creatinine clearance, which is not assessed directly in daily practice, was not provided in the survey, but could be calculated. Patients 1 and 3 had severe renal impairment, with similar calculated creatinine clearances (25 and 28 ml/min, respectively) but markedly different creatinine levels (1.2 and 2.2 mg/dl, respectively). Patients 2 and 4 had a creatinine level of 1.0 mg/dl, with, respectively, mild renal impairment (calculated clearance of 57 ml/min) and slight renal impairment (calculated clearance of 64 ml/ min). The patients were supposed to have just arrived in the department with the following order: (1) gentamicin sulfate 1 mg/kg three times a day; (2) diclofenac sodium 50 mg twice a day; (3) amlodipine bensylate 10 mg per day. The resident was to ratify each patient s order or to change the dosage (with a choice between reducing the concentration or volume required per dose, or increasing the dosing interval). Another option was to discontinue the order. A fourth drug, enalapril maleate, was to be started, in the context of high blood pressure, with three possible dosages and the possibility of not prescribing it. We considered the initial prescription of enalapril before further adjustment, which could have been made according to enalapril titration. Gold standard 236

3 Prescribing in renal impairment Table 1 Vignettes simulating drug prescription in four patients with various degrees of renal impairment Patient 1: female Patient 2: male Patient 3: female Patient 4: female (age 79 years, (age 80 years, (age 36 years, (age 48 years, weight 40 kg) weight 70 kg) weight 50 kg) weight 60 kg) Order: Cr 1.2 mg/dl Order: Cr 1.0 mg/dl Order: Cr 2.2 mg/dl Order: Cr 1.0 mg/dl... Gentamicin: 1 mg/kg 3 40 mg per day 3 70 mg per day 3 50 mg per day 3 60 mg per day 1 three times a day 3 20 mg per day 3 40 mg per day mg per day 3 30 mg per day 3 10 mg per day mg per day 3 10 mg per day mg per day Discontinue the order Discontinue the order Discontinue the order Discontinue the order Diclofenac: 50 mg twice a day 50 mg twice a day 50 mg twice a day 1 50 mg twice a day 50 mg twice a day 1 50 mg once a day 50 mg once a day 50 mg once a day 50 mg once a day 25 mg twice a day 25 mg twice a day 25 mg twice a day 25 mg twice a day Discontinue the order 1 Discontinue the order Discontinue the order 1 Discontinue the order Amlodipine: 10 mg per day 10 mg per day 1 10 mg per day 1 10 mg per day 1 10 mg per day 1 5 mg once a day 5 mg once a day 5 mg once a day 5 mg once a day 10 mg 1 day out of 2 10 mg 1 day out of 2 10 mg 1 day out of 2 10 mg 1 day out of 2 Discontinue the order Discontinue the order Discontinue the order Discontinue the order Enalapril: Start a treatment mg per day mg per day mg per day mg per day (high blood pressure) 5 10 mg per day 5 10 mg per day mg per day 5 10 mg per day 1 20 mg per day 20 mg per day 20 mg per day 20 mg per day Discontinue the order Discontinue the order Discontinue the order Discontinue the order Cr, serum creatinine level. 1 Recommended order. Creatinine clearance was not provided in the clinical case. It had to be calculated by the residents: patients 1 and 3 have severe renal impairment, with a calculated creatinine clearance <30 ml/min; patient 2 has mild renal impairment, with a calculated creatinine clearance <60 ml/min; patient 4 has slight renal impairment, with a calculated creatinine clearance of 64 ml/min. Authorities. It corresponds to the Physician s Desk Reference and is the French reference for prescription. Commonly consulted by physicians, it may be used as formal evidence in legal procedures. Participants and data Analysis A descriptive analysis of data was made. According to the calculated clearance of creatinine, the appropriateness of the 16 orders was determined (four medications and four patients ). The number of appropriate orders per residents was determined (range 0 16). A chi-square test of association was used to compare the frequency of inappropriate orders, with respect to: (1) whether or not an adjustment was required; (2) patient 1 versus patient 3 similar clearances but different serum creatinine levels; and (3) patient 1 versus patient 2 similar levels of serum creatinine and different renal function. To take into account multiple testing, significance was set In French hospitals, residents change departments every 6 months during the 2 5 years of their residency. The study took place at the hospital administration office, where the residents come to register at the start of the semester. An investigator was present at the administration office to deliver the questionnaire to the residents. They completed this anonymous questionnaire alone and returned it immediately to the investigator. The investigator specified that the purpose at P = 0.01 instead of P = of the study was not to test the knowledge of the residents, but to comprehend their behavior when prescribing drugs in renal impairment. Residents were encouraged to act as they Results would for genuine patients, and to check any document they would use for usual prescribing, but not more. A Vidal dictionary was placed in an obvious position near the in- vestigator, and was available for consultation if the residents requested it. Residents were also told to spend the same time on the questionnaire as they would actually take to write orders. Among the 118 residents, 71 (60% of the residents) came to register at the hospital administration office at the beginning of the semester. All completed the questionnaire. Of these, 73% were medical residents, 3% were residents in anesthesia, and 24% had a surgical speciality. Fifty percent had already 237

4 L. Salomon et al. Table 2 Number (and percentage) of appropriate orders per resident Score Appropriate orders per resident n (%) Total performed at least six postgraduate semesters, with seniority ranging from postgraduate semester 1 to 10 (out of 10). The necessity of dosage adjustment in renal impairment was considered to be a frequent problem in hospital prescription by 85% of the residents (n = 58). Among the residents, 20% (n = 13) reported checking if the dosage needs adjustment when serum creatinine is >0.9 mg/dl, 35% (n = 23) when creatinine is >1.2 mg/dl, 35% (n = 23) when creatinine is >1.7 mg/dl, and 6% (n = 4) when creatinine is >2.3 mg/dl. Four percent of the residents (n = 3) reported checking if the dosage needs adjustment for any level of serum creatinine. Among the 16 simulated orders, the median number of appropriate orders per resident was nine (range 0 15) (Table 2). Prescription of gentamicin sulfate (Table 3) For gentamicin sulfate, 62% of the respondents prescribed a dosage that was not appropriate. The lowest percentage of inappropriate orders was observed for patient 4 (26% of inappropriate orders), for whom the dosage did not require adjustment. The highest percentages of inappropriate orders were observed for patients 1 and 3 (78% and 79% of inappropriate orders, respectively), for whom the dosage needed adjustment. When the order needed to be modified (patients 1, 2, and 3), inappropriate orders were written more often than when no adjustment was required (74% versus 26%; P <10 4 ). For similar clearances (patients 1 and 3), the prescription Table 3 Simulated prescribing behavior of the residents for four patients with various degrees of renal impairment Clinical cases Patient 1 Patient 2 Patient 3 Patient 4 Cr 1.2 mg/dl, CrCl 25 ml/min Cr 1.0 mg/dl, CrCl 57 ml/min Cr 2.2 mg/dl, CrCl 28 ml/min Cr 1.0 mg/dl, CrCl 64 ml/min G D A E G D A E G D A E G D A E... Appropriate order (%) Maintained Decreased Discontinued Inappropriate order (%) Maintained (overdose) Decreased (overdose) Underdose Discontinued Number of responders Cr, serum creatinine level; CrCl, creatinine clearance; G, gentamicin sulfate; D, diclofenac sodium; A, amlodipine bensylate; E, enalapril maleate. 238

5 Prescribing in renal impairment of gentamicin was stopped more frequently in the patient patients. Although they adjusted the dosage, 13% and 9% of with the highest levels of serum creatinine (40% for 2.2 mg/ the residents still ordered an overdose for patients 1 and 3, dl creatinine versus 20% for 1.2 mg/dl; P = 0.009). respectively. For patients 2 and 4, 57% and 36% of the residents For similar levels of serum creatinine (1.2 and 1.0 mg/dl), overadjusted the dosage, respectively, leading to an underdose. there was no difference in the proportion of residents who reduced the dosage of gentamicin (28% for patient 1 and 12% for patient 4, respectively; P > 0.01), although patient 1 Discussion had a severe renal impairment and patient 2 had a mild renal impairment. This dosage adjustment led to an overdose for Medication misuse has frequently been reported and may patient 1, and to an underdose for patient 2. cause iatrogenic complications, which is an important cause of morbidity and mortality in hospitalized patients [6,14 17]. This Prescription of diclofenac sodium (Table 3) study revealed a lack of dosage adjustment for medications in patients with renal impairment. Although most residents in our For diclofenac sodium, 42% of the responders prescribed a hospital were aware of the necessity to adjust dosage in renal dosage that was not adjusted to the renal function of their impairment, very few of them (5%) reported checking whether patients. The lowest percentage of inappropriate orders was their order needed adjustment without an increase in serum observed for patient 4 (16% of inappropriate orders), for whom creatinine. This result indicates that the residents do not calculate the dosage did not require adjustment. The highest percentage the clearance of creatinine for every patient and thus may of inappropriate orders was observed for patient 1 (65% of underestimate the depth of renal impairment, since an apinappropriate orders), whose order needed to be discontinued. parently minor increase in serum creatinine can reflect a marked When the order required adjustment (patients 1 and 3), fall in glomerular filtration rate (Figure 1). inappropriate orders were written more often than when no A limitation of the study is that although it is supposed adjustment was needed (55% versus 29%; P = 10 3 ). to examine residents performance in their daily routine, the Considering patients with similar clearances, 55% of the residents may have either increased awareness in a simulated residents discontinued the order of diclofenac for patient 3, prescribing situation or decreased their concern about ficwho had the highest level of serum creatinine (2.2 mg/dl), titious patients. However, as demonstrated by Peabody, using compared with 35% of residents discontinuing the order for patient 1 (creatinine 1.2 mg/dl). Taking into account the vignettes is a relevant and valid method to assess quality correction for multiple tests, this difference is not significant of care, compared with chart abstraction and standardized (P = 0.02). patients [12]. Using vignettes allows assessment of the quality For similar levels of serum creatinine (1.2 and 1.0 mg/dl), of care provided by a group of physicians, and controls for there was no difference in the proportions of residents who case mix. It appears to be a valid and comprehensive method reduced the dosage of diclofenac (30% for patient 1 and that focuses directly on the process of care provided in actual 27% for patient 2, respectively; P > 0.05), although patient 1 clinical practice. The conclusions of surveys using vignettes, had a severe renal impairment and patient 2 had a mild renal therefore, may more likely be generalizable than surveys impairment. This dosage adjustment led to an overdose for performed in a population of patients. patient 1, and to an underdose for patient 2. The study took place at the hospital administration office, where the residents are supposed to come and register at the Prescription of amlodipine bensylate (Table 3) beginning of the semester, except for those who had already worked as residents or as students in the hospital. Since the For amlodopine bensylate, 31% of the responders wrote an policy of the hospital concerning medication prescribing and order that was not appropriate for the renal function of their dosage adjustment is similar to that of the other teaching patients. The lowest percentage of inappropriate orders was hospitals where the residents could have worked, we assumed observed for patient 4 (21% of inappropriate orders), the that the non responders (mostly residents who had already highest percentage of inappropriate orders were observed for worked in the hospital) would not differ from the responders patient 3 (42% of inappropriate orders). with regards to their prescribing behavior. All the residents who Although no dosage adjustment was required, 3% of the came to the administration office completed the questionnaire. residents discontinued the medication and 28% decreased The residents were told that their knowledge of the drugs the dosage of amlodopine, which led to an underdose. was not being tested and were encouraged to act as they would The proportion of residents who inappropriately modified in their daily routine. Thus, the Vidal dictionary was set on the the orders was similar when comparing (1) patient 1 with table and the residents were free to consult it to complete the patient 3 (who have both severe renal impairment, but questionnaire. During data collection, investigators noted that different levels of creatinine), and (2) patient 1 with patient residents rarely checked their orders in the Vidal dictionary and 2 (who have severe and mild renal impairment, but similar rarely calculated creatinine clearance. This observation was levels of creatinine). confirmed by the results of the study: there was no difference Prescription of enalapril maleate (Table 3) in the percentage of residents who reduced the dosage of gentamicin for patients 1 and 2, who had similar levels of For enalapril maleate, 52% of the responders prescribed a serum creatinine (1.2 and 1.0 mg/dl, respectively). Yet this dosage that was not adjusted to the renal function of their adjustment led to an overdose for patient 1, who actually had 239

6 L. Salomon et al. severe renal impairment, and to an underdose for patient 2, 4. Drayer DE. Active drug metabolites and renal failure. Am J who had mild renal impairment. Similar results were observed Med 1977; 62: for the prescription of diclofenac and confirm that most 5. Rind DM, Safran C, Phillip RS et al. Effect of computer-based residents consider serum creatinine level as an indicator of renal alerts on the treatment and outcomes of hospitalised patients. function, instead of calculating creatinine clearance, neglecting Arch Intern Med 1994; 154: patients age and weight. 6. Leape LL, Bates DW, Cullen DJ et al. System analysis of adverse In prescribing amlodipine bensylate, which required no drug events. J Am Med Assoc 1995; 274: adjustment, some residents inappropriately reduced the dosfrom serum creatinine. Nephron 1976; 16: Cockcroft DW, Gault MH. Prediction of creatinine clearance age. Similarly, some residents prescribed the lowest dosage of enalapril maleate where a higher dose could have been 8. Preston SL, Briceland LL, Lomaestro BM, Lesar TS, Bailie ordered. (Since dose titration is commonly performed with GR, Drusano GL. Dosing adjustment of 10 antimicrobials for patients with renal impairment. Ann Pharmacother 1995; 29: this medication, residents were told that they had to start the treatment, i.e. to write the order before dose titration.) Thus, residents were particularly cautious in their orders, but 9. Yager J, Linn LS, Leake B, Gastaldo G, Palkowski C. Initial clinical judgment by internists, family physicians, and psyinappropriately adjusted the treatment, risking underdosage, chiatrists in response to patient vignettes. I. assessment of rather than consulting the Vidal dictionary. problems and diagnostic possibilities. Gen Hosp Psychiatry 1986; To improve prescriptions in renal impairment, it would be 8: necessary to implement actions to draw physicians attention 10. Tait RC, Chibnall JT. Physician judgments of chronic pain to the importance of creatinine clearance and to provide them, patients. Soc Sci Med 1997; 45: at the time of prescription, with reminders of prescription 11. Colenda CC, Rapp SR, Leist JC, Poses RM. Clinical variables guidelines in renal impairment. A systematic review of con- influencing treatment decisions for agitated dementia patients: trolled studies has shown that among 14 studies assessing survey of physician judgments. J Am Geriatr Soc 1996; 44: this issue, six revealed an actual impact of computerized prescription on quality of care [18]. Therefore, implementing 12. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. computing systems with reminders at the time of prescription Comparison of vignettes, standardized patients, and chart ab- could be of great interest. The implementation of computing straction: a prospective validation study of 3 methods for systems that screen for inappropriate dosage and provide measuring quality. J Am Med Assoc 2000; 283: reminders of prescription guidelines in renal impairment has 13. Vidal Dictionary. The Vidal Editions: Paris, already been reported, with a positive impact on the quality 14. Bates DW, Cullen DJ, Laird N et al. Incidence of adverse drug of medical orders [5,19 21]. events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. J Am Med Assoc 1995; 274: Conclusions 15. Leape LL. Error in medicine. J Am Med Assoc 1994; 272: Although residents believe that dosage adjustment is a fre- 16. Lesar TS, Briceland L, Delcoure K, Parmalee JC, Masta-Gornic quent problem in hospitalized patients, most of those in our V, Pohl H. Medication prescribing errors in a teaching hospital. study did not properly determine the renal function of J Am Med Assoc 1990; 263: fictitious patients and did not seek information on adjusting 17. Brennan TA, Leape LL, Laird NM et al. Incidence of adverse dosages of medications that are metabolized or excreted by events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991; 324: the kidney, or of nephrotoxic medications Considering the iatrogenic risk and irreversible renal impairment related to the lack of dosage adjustment, attention 18. Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer- based clinical decision support systems on physician pershould be drawn to the need to increase residents awareness formance and patient outcomes: a systematic review. JAmMed of dosage adjustment in renal impairment and to provide Assoc 1998; 280: them with better information on their patients renal function. 19. Peterson JP, Colucci VJ, Schiff SE. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs. Am J Hosp Pharm 1991; 48: References 20. Goldberg DE, Baardsgaard G, Johnson MT, Jolowsky CM, Shepherd M, Peterson CD. Computer-based program for iden- 1. Alkhunaizi AM, Schrier RW. Management of acute renal failure: tifying medication orders requiring dosage modification based new perspectives. Am J Kidney Dis 1996; 28: on renal function. Am J Hosp Pharm 1991; 48: Cantu TG, Ellerbeck EF, Yun SW, Castine SD, Kornhauser 21. McMullin ST, Reichley RM, Kahn MG, Dunagan WC, Bailey DM. Drug prescribing for patients with changing renal function. TC. Automated system for identifying potential dosage problems at a large university hospital. Am J Health Syst Pharm 1997; 54: Am J Hosp Pharm 1992; 49: Wong NA, Jones HW. An analysis of discharge drug prescribing among elderly patients with renal impairment. Postgrad Med J 1998; 74: Accepted for publication 5 February

The Rate of Antibiotic Dosage Adjustment in Renal Dysfunction

The Rate of Antibiotic Dosage Adjustment in Renal Dysfunction Iranian Journal of Pharmaceutical Research (2012), 11 (1): 157-161 Received: February 2011 Accepted: May 2011 Copyright 2012 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health

More information

Drug Dosage Adjustment of Patients with Impaired Renal Function at Hospital Discharge in a Teaching Hospital

Drug Dosage Adjustment of Patients with Impaired Renal Function at Hospital Discharge in a Teaching Hospital Original Article J Nepal Health Res Counc 2014 Jan;12(26):54-8 Drug Dosage Adjustment of Patients with Impaired Renal Function at Hospital Discharge in a Teaching Hospital Sah SK, 1 Wanakamanee U, 1 Lerkiatbundit

More information

The estimation of kidney function with different formulas in overall population

The estimation of kidney function with different formulas in overall population 137 G E R I A T R I A 213; 7: 137-141 Akademia Medycyny ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Otrzymano/Submitted: 28.8.213 Zaakceptowano/Accepted: 2.9.213 The estimation of kidney function with different

More information

Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine y

Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine y eliminated through the kidney and thus adequate renal function is important to avoid toxicity. The proper dosing of medications for patients with renal impairment can maximize therapeutic efficacy, minimize

More information

Antibiotics requiring dosage adjustment in community acquired pneumonia patients with renal impairment

Antibiotics requiring dosage adjustment in community acquired pneumonia patients with renal impairment 1 Antibiotics requiring dosage adjustment in community acquired pneumonia patients with renal impairment Md Aslam Ali Hashmi 1, Meer Mudabbir Ali 1, MA Iqbal Rasheed 1, Syed Fawaz Hussain 1, Syed Areefulla

More information

Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients

Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients Original article Annals of Oncology 15: 291 295, 2004 DOI: 10.1093/annonc/mdh079 Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients G.

More information

Special Challenges and Co-Morbidities

Special Challenges and Co-Morbidities Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine

More information

Evaluation of Vancomycin Continuous Infusion in Trauma Patients

Evaluation of Vancomycin Continuous Infusion in Trauma Patients OBJECTIVES Evaluation of Vancomycin Continuous Infusion in Trauma Patients Brittany D. Bissell, Pharm.D. PGY-2 Critical Care Pharmacy Resident Jackson Memorial Hospital Miami, Florida Evaluate the potential

More information

Carboplatin Time to Drop the Curtain on the Dosing Debate

Carboplatin Time to Drop the Curtain on the Dosing Debate Carboplatin Time to Drop the Curtain on the Dosing Debate Jon Herrington, Pharm.D., BCPS, BCOP Judith Smith, Pharm.D., BCOP, CPHQ, FCCP, FISOPP Scott Soefje, Pharm.D., MBA, BCOP Heimberg J, et al. N Engl

More information

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title

More information

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes

More information

Development of Renal Dosing Guidelines: A Prospective Study

Development of Renal Dosing Guidelines: A Prospective Study Review Article Development of Renal Dosing Guidelines: A Prospective Study Varun Parvathagiri 1, Aparna Yerramilli 2, Somasekhar Mudigonda 3, Swathi Kethavath 1, Nikitha Rao Yeravalli 1, Navya Teja Peteti

More information

Patterns of ADRs and Risk Factors Involved: Study In Cardiology Unit Of An Indian Tertiary Care Center

Patterns of ADRs and Risk Factors Involved: Study In Cardiology Unit Of An Indian Tertiary Care Center ISPUB.COM The Internet Journal of Pharmacology Volume 8 Number 1 Patterns of ADRs and Risk Factors Involved: Study In Cardiology Unit Of An Indian Tertiary Care Center S Kaur, V Kapoor, R Mahajan, M Lal,

More information

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW: Amikacin is a partially restricted (amber) antibiotic for the treatment of infections due to gentamicin resistant Gram negative bacilli or as advised by microbiology. As with other aminoglycosides, therapeutic

More information

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD A Practical Approach to Chronic Kidney Disease Management for the Primary Care Practioner: A web-site sponsored by the National Kidney Foundation of Connecticut Robert Reilly, M.D. Acknowledgements National

More information

Cystatin C: A New Approach to Improve Medication Dosing

Cystatin C: A New Approach to Improve Medication Dosing Cystatin C: A New Approach to Improve Medication Dosing Erin Frazee Barreto, PharmD, MSc, FCCM Assistant Professor of Pharmacy and Medicine Kern Scholar, Center for the Science of Health Care Delivery

More information

Zhao Y Y et al. Ann Intern Med 2012;156:

Zhao Y Y et al. Ann Intern Med 2012;156: Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled

More information

Renal function vs chemotherapy dosing

Renal function vs chemotherapy dosing Renal function vs chemotherapy dosing Jenny Casanova Senior Clinical Pharmacist Repatriation General Hospital Daw Park 1 Methods of estimating renal function Cockcroft-Gault (1976) C-G using ideal vs actual

More information

Introduction. J Mwanza 1, R Paul 1, JM Ncheka 1, P Petlovani 1. 1.University of Zambia School of Medicine, Department of Psychiatry

Introduction. J Mwanza 1, R Paul 1, JM Ncheka 1, P Petlovani 1. 1.University of Zambia School of Medicine, Department of Psychiatry RESEARCH ARTICLE Appropriateness of antipsychotic drugs prescribed for First episode psychosis by clinicians at Chainama Hills college hospital in Lusaka J Mwanza 1, R Paul 1, JM Ncheka 1, P Petlovani

More information

Renal Function and Associated Laboratory Tests

Renal Function and Associated Laboratory Tests Renal Function and Associated Laboratory Tests Contents Glomerular Filtration Rate (GFR)... 2 Cockroft-Gault Calculation of Creatinine Clearance... 3 Blood Urea Nitrogen (BUN) to Serum Creatinine (SCr)

More information

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

QUICK REFERENCE FOR HEALTHCARE PROVIDERS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

Assessing Renal Function: What you Didn t Know You Didn t Know

Assessing Renal Function: What you Didn t Know You Didn t Know Assessing Renal Function: What you Didn t Know You Didn t Know Presented By Tom Wadsworth PharmD, BCPS Associate Clinical Professor UAA/ISU Doctor of Pharmacy Program Idaho State University College of

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

ARTICLE. Evaluation of a Method to Reduce Over-the-Counter Medication Dosing Error

ARTICLE. Evaluation of a Method to Reduce Over-the-Counter Medication Dosing Error ARTICLE Evaluation of a Method to Reduce Over-the-Counter Medication Dosing Error Karen S. Frush, MD; Xuemei Luo, PhD; Paul Hutchinson, BS; Jennifer N. Higgins, BS Objectives: To introduce a simple method

More information

ECN Protocol Book. Generic Chemotherapy Protocol Guidelines. ECN_Protocol_Book_generic chemotherapy protocol guidelines guidelines_1

ECN Protocol Book. Generic Chemotherapy Protocol Guidelines. ECN_Protocol_Book_generic chemotherapy protocol guidelines guidelines_1 ECN Protocol Book Generic Chemotherapy Protocol Guidelines Name of person presenting document: Reason for document development: Names of development team: Specify groups of staff to whom the document relates:

More information

www.usrds.org www.usrds.org 1 1,749 + (2,032) 1,563 to

More information

Perfect Endings. Home Alone. Senior Estimate. Staying Alive. Medication Madness

Perfect Endings. Home Alone. Senior Estimate. Staying Alive. Medication Madness Senior Estimate Home Alone Staying Alive Perfect Endings Medication Madness 10 10 10 10 10 20 20 20 20 20 30 30 30 30 30 40 40 40 40 40 50 50 50 50 50 Senior Estimate - 10 Patients who have multiple interacting

More information

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing ProMedica Health System Clinical Interdepartmental Policy and Procedure: Section: Policy: Date: Subject: Pharmacy Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

More information

Decreasing Falls with the Automation of Beers Criteria Medications

Decreasing Falls with the Automation of Beers Criteria Medications Decreasing Falls with the Automation of Beers Criteria Medications Session #312, February 15, 2019 Siraj Anwar, Associate Chief Medical Informatics Officer Memorial Hermann Health System 1 Conflict of

More information

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives

2017/3/7. Evaluation of GFR. Chronic Kidney Disease (CKD) Serum creatinine(scr) Learning Objectives Evaluation of egfr and mgfr in CKD Use of CKD staging with case scenario Assessment of kidney function in CKD in adults Learning Objectives 台大雲林分院楊淑珍藥師 2017/03/11 Chronic Kidney Disease (CKD) Based on

More information

Foo Koon Mian Pharmacy Resident National University of Singapore Hematology / Oncology Pharmacy Residency Program. 4th APOPC November 2012

Foo Koon Mian Pharmacy Resident National University of Singapore Hematology / Oncology Pharmacy Residency Program. 4th APOPC November 2012 Foo Koon Mian Pharmacy Resident National University of Singapore Hematology / Oncology Pharmacy Residency Program 4th APOPC 2012 1-3 November 2012 1 Outline Use of BSA in chemotherapy dosing Chemotherapy

More information

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult) VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin

More information

Sebastião Rodrigues Ferreira-Filho, Camila Caetano Cardoso, Luiz Augusto Vieira de Castro, Ricardo Mendes Oliveira, and Renata Rodrigues Sá

Sebastião Rodrigues Ferreira-Filho, Camila Caetano Cardoso, Luiz Augusto Vieira de Castro, Ricardo Mendes Oliveira, and Renata Rodrigues Sá SAGE-Hindawi Access to Research International Nephrology Volume 211, Article ID 626178, 4 pages doi:1.461/211/626178 Research Article Comparison of Measured Creatinine Clearance and Clearances Estimated

More information

(telavancin) Healthcare Professional s Guide. Version 2, 4 November 2014

(telavancin) Healthcare Professional s Guide. Version 2, 4 November 2014 VIBATIV (telavancin) Healthcare Professional s Guide Version 2, 4 November 2014 1 Table of Contents Introduction... 3 About Vibativ / Therapeutic indications... 3 Antimicrobial spectrum of activity for

More information

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University Estimating renal function An accurate estimation of renal

More information

PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN

PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN VI.1 Summary of activities in the risk management plan The summary below was prepared based on the information included in Part II, IV and V of the present

More information

Katy Trinkley PharmD, BCACP Tiffany Goldberg Pharm D Candidate Katie Heist MD

Katy Trinkley PharmD, BCACP Tiffany Goldberg Pharm D Candidate Katie Heist MD Katy Trinkley PharmD, BCACP Tiffany Goldberg Pharm D Candidate Katie Heist MD Metformin: Only oral diabetes medication with proven benefits on cardiovascular morbidity and mortality Inexpensive medication

More information

Have you seen a patient like Carol *?

Have you seen a patient like Carol *? (linagliptin) 5mg tablets Have you seen a patient like Carol *? *Hypothetical patient profile Carol * : 70 years old Retired schoolteacher *Hypothetical patient profile CAROL*: T2D patient with moderate

More information

Selected Clinical Calculations Chapter 10. Heparin-Dosing calculations

Selected Clinical Calculations Chapter 10. Heparin-Dosing calculations Selected Clinical Calculations Chapter 10 Heparin-Dosing calculations Heparin is a heterogeneous group of muco-polysaccharides that have anticoagulant properties (slows clotting time). Heparin salt, as

More information

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

Title: High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis

Title: High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis Author's response to reviews Title: High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis Authors: Alexandre Lautrette (alautrette@chu-clermontferrand.fr)

More information

MEDICATION ERRORS AMONG GERIATRICS AT THE OUTPATIENT PHARMACY IN A TEACHING HOSPITAL IN KELANTAN

MEDICATION ERRORS AMONG GERIATRICS AT THE OUTPATIENT PHARMACY IN A TEACHING HOSPITAL IN KELANTAN Malaysian Journal of Medical Sciences, Vol. 11, No. 2, July 2004 (52-58) ORIGINAL ARTICLE MEDICATION ERRORS AMONG GERIATRICS AT THE OUTPATIENT PHARMACY IN A TEACHING HOSPITAL IN KELANTAN Dellemin Che Abdullah,

More information

ORIGINAL RESEARCH ARTICLE

ORIGINAL RESEARCH ARTICLE Journal of Chitwan Medical College 2015; 5(12): 20-24 Available online at: www.jcmc.cmc.edu.np ISSN 2091-2889 (Online) ISSN 2091-2412 (Print) JOURNAL OF CHITWAN MEDICAL COLLEGE JCMC ESTD 2010 ORIGINAL

More information

Have you seen a patient like Elaine *?

Have you seen a patient like Elaine *? (linagliptin) 5mg tablets Have you seen a patient like Elaine *? *Hypothetical patient profile Elaine * : 60 years old Housewife *Hypothetical patient profile ELAINE*: T2D Patient with early signs of kidney

More information

Prevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan

Prevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention And Treatment of Diabetic Nephropathy MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention Tight glucose control reduces the development of diabetic nephropathy Progression

More information

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis SA-PO546 Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Johan Vande Walle, 1 Larry A. Greenbaum, 2 Camille L. Bedrosian, 3 Masayo Ogawa, 3 John F. Kincaid,

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

N.U.A.G.E.S: A survey of nebulisation practice in France with regard to ERS guidelines

N.U.A.G.E.S: A survey of nebulisation practice in France with regard to ERS guidelines Respiratory Medicine (2007) 101, 2561 2565 SHORT COMMUNICATION N.U.A.G.E.S: A survey of nebulisation practice in France with regard to ERS guidelines M. de Monte a, J. Scruignec a, J.C. Dubus b,c, J.P.

More information

Urinary Tract Infection in Chronic Renal Insufficiency: A Case Study

Urinary Tract Infection in Chronic Renal Insufficiency: A Case Study CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Case Study Urinary Tract Infection in Chronic Renal Insufficiency:

More information

IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE:

IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE: IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE: IMPACT OF A PHARMACY DEPARTMENT-WIDE APPROACH IN A COMMUNITY HOSPITAL SETTING November 2014 Monica Dorobisz,

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Rexulti) Reference Number: NE.PMN.68 Effective Date: 01/01/2017 Last Review Date: Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of this

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

Modifying Drug Dosing for Patients with Renal Insufficiency

Modifying Drug Dosing for Patients with Renal Insufficiency Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/focus-on-pharmacy/modifying-drug-dosing-for-patients-with-renalinsufficiency/3427/

More information

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Age and Kidney Weight renal weight and thickening of the vascular intima Platt et al. Gerentology 1999;45:243-253

More information

Outpatient Prescription Intervention Activities by Pharmacists in a Teaching Hospital

Outpatient Prescription Intervention Activities by Pharmacists in a Teaching Hospital Malaysian Journal of Pharmacy 2003;1(3):86-90 Research article Outpatient Prescription Intervention Activities by Pharmacists in a Teaching Hospital Chua Siew Siang 1 *, Kuan Mun Ni 1, Mohamed Noor bin

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Rexulti) Reference Number: CP.PMN.68 Effective Date: 11.05.15 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important Reminder

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil Specific management of IgA nephropathy: role of fish oil Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Early and prolonged treatment with fish oil may retard

More information

MICHAEL PRITCHARD. most of the high figures for psychiatric morbidity. assuming that a diagnosis of psychiatric disorder has

MICHAEL PRITCHARD. most of the high figures for psychiatric morbidity. assuming that a diagnosis of psychiatric disorder has Postgraduate Medical Journal (November 1972) 48, 645-651. Who sees a psychiatrist? A study of factors related to psychiatric referral in the general hospital Summary A retrospective study was made of all

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of

More information

WEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47

WEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47 MPharm Programme Acute Kidney Injury Alan M. Green 2017 Slide 1 of 47 Overview Renal Function What is it? Why does it matter? What causes it? Who is at risk? What can we (Pharmacists) do? How do you recognise

More information

TDM of Aminoglycoside Antibiotics

TDM of Aminoglycoside Antibiotics TDM Lecture 3 5 th Stage TDM of Aminoglycoside Antibiotics The aminoglycoside antibiotics are widely used for the treatment of gram-negative infections, often in combination with a β-lactam antibiotic

More information

(Max 2 g) = to nearest 250 mg

(Max 2 g) = to nearest 250 mg Appendix 1 (part 1 of 8): Rubric for competency assessment of pharmacists prescribing and managing vancomycin Empiric Dosing Phase Pts Yes No Data Error OP Did the pharmacist document the indication 2

More information

HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE STUDY

HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE STUDY Journal of Aging Research & Clinical Practice Volume 6, 2017 J Aging Res Clin Practice 2017;inpress Published online in press HUGE EQUATION ACCURACY FOR SCREENING CHRONIC KIDNEY DISEASE: A PROSPECTIVE

More information

Use of renal risk drugs in hospitalized patients with impaired renal function an underestimated problem?

Use of renal risk drugs in hospitalized patients with impaired renal function an underestimated problem? Nephrol Dial Transplant (2006) 21: 3164 3171 doi:10.1093/ndt/gfl399 Advance Access publication 31 July 2006 Original Article Use of renal risk drugs in hospitalized patients with impaired renal function

More information

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Leigh Briscoe-Dwyer, PharmD, BCPS, FASHP Chief Pharmacy and Medication Safety Officer North Shore Long Island Jewish Health

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article ROLE OF CLINICAL PHARMACIST IN DOSE ADJUSTMENT OF RENALLY ELIMINATED DRUGS IN CARDIAC PATIENTS WITH RENAL IMPAIRMENT

More information

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?

Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients? Diabetes Care Publish Ahead of Print, published online October 3, 2008 The MCQ equation in DM2 patients Is the new Mayo Clinic Quadratic (MCQ) equation useful for the estimation of glomerular filtration

More information

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE

Measurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE Measurement and Estimation of renal function Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE 1 2 How to estimate GFR? How to measure GFR? How to estimate GFR? How to measure GFR?

More information

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics

More information

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Drug Dosing in Renal Insufficiency Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila Declaration of Conflict of Interest For today s lecture on Drug Dosing in Renal

More information

Impact of Isotope Dilution Mass Spectrometry (IDMS) Standardization on Carboplatin Dose and Adverse Events

Impact of Isotope Dilution Mass Spectrometry (IDMS) Standardization on Carboplatin Dose and Adverse Events Impact of Isotope Dilution Mass Spectrometry (IDMS) Standardization on Carboplatin Dose and Adverse Events Justin Lawson, Emory Healthcare Jeffrey Switchenko, Emory University Trevor McKibbin, Emory University

More information

Effects of Renal Disease on Pharmacokinetics

Effects of Renal Disease on Pharmacokinetics Effects of Renal Disease on Pharmacokinetics Juan J. L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program October 14, 2010 Office of Clinical Research Training and Medical Education National

More information

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro IV Vancomycin dosing and Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary Medicine Unique

More information

Clinical Policy: Cinacalcet (Sensipar) Reference Number: CP.PHAR.61 Effective Date: Last Review Date: Line of Business: Medicaid

Clinical Policy: Cinacalcet (Sensipar) Reference Number: CP.PHAR.61 Effective Date: Last Review Date: Line of Business: Medicaid Clinical Policy: (Sensipar) Reference Number: CP.PHAR.61 Effective Date: 05.01.11 Last Review Date: 02.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important

More information

Research Article EVALUATION OF THE APPROPRIATENESS OF DRUG DOSAGE IN RENAL IMPAIRED PATIENTS IN A TERTIARY CARE HOSPITAL

Research Article EVALUATION OF THE APPROPRIATENESS OF DRUG DOSAGE IN RENAL IMPAIRED PATIENTS IN A TERTIARY CARE HOSPITAL ISSN 2395-3411 Available online at www.ijpacr.com 18 Research Article EVALUATION OF THE APPROPRIATENESS OF DRUG DOSAGE IN RENAL IMPAIRED PATIENTS IN A TERTIARY CARE HOSPITAL M. Rangapriya, Clinsy Cleto,

More information

D DAVID PUBLISHING. Evaluation of the Effectiveness of a Vancomycin Nomogram at Predicting Trough Levels within a Therapeutic Range. 1.

D DAVID PUBLISHING. Evaluation of the Effectiveness of a Vancomycin Nomogram at Predicting Trough Levels within a Therapeutic Range. 1. Journal of Pharmacy and Pharmacology 2 (2014) 713-721 doi: 10.17265/2328-2150/2014.12.004 D DAVID PUBLISHING Evaluation of the Effectiveness of a Vancomycin Nomogram at Predicting Trough Levels within

More information

Essential Shared Care Agreement: Lithium

Essential Shared Care Agreement: Lithium Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed

More information

REVISITING THE PHARMACOKINETICS IN PATIENTS

REVISITING THE PHARMACOKINETICS IN PATIENTS REVISITING THE PHARMACOKINETICS IN PATIENTS WITH IMPAIRED RENAL FUNCTION IN THE LIGHT OF THE LATEST FDA AND EMA GUIDELINES 3 RD CONFERENCE OF EUROPEAN PHARMACOLOGICAL SOCIETIES EUROPEAN COMPETITIVENESS

More information

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2013 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points Set I 20 pts Set II 20 pts Set III 20 pts Set IV 20 pts Set

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES Specific effects of calcium channel blockers in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Non-dihydropyridine calcium channel

More information

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007 Impact of Obesity on Medication Dosing John C. Williamson, PharmD, BCPS, AAHIVE Wake Forest University Baptist Medical Center Winston-Salem, NC Objectives Determine what constitutes the various forms of

More information

Renal Data from Asia Africa

Renal Data from Asia Africa Saudi J Kidney Dis Transpl 2012;23(2):403-408 2012 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Renal Data from Asia Africa Medication Prescribing Patterns

More information

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31 Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to

More information

NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas R. Frieden, MD, MPH Commissioner

NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas R. Frieden, MD, MPH Commissioner NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas R. Frieden, MD, MPH Commissioner Interim Guidance on Dosage, Precautions, and Adverse Effects of Antiviral Medications used to Treat or Prevent

More information

Chronic Kidney Disease Prevalence and Rate of Diagnosis

Chronic Kidney Disease Prevalence and Rate of Diagnosis The American Journal of Medicine (2007) 120, 981-986 CLINICAL RESEARCH STUDY Chronic Kidney Disease Prevalence and Rate of Diagnosis Timothy P. Ryan, PhD, a James A. Sloand, MD, b Paul C. Winters, MS,

More information

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007

More information

AUDIT REPORT. Salisbury District Hospital. Odstock Road. Salisbury. Wiltshire. February Page 1 of 20

AUDIT REPORT. Salisbury District Hospital. Odstock Road. Salisbury. Wiltshire. February Page 1 of 20 AUDIT REPORT Prescribing of Treatment Dose Dalteparin Based on Patient Weight and Renal Function, and the Recording of these Parameters on the Drug Chart. Author : Location : Janeen Linsley Salisbury District

More information

StRs and CT doctors in haematology. September Folinic acid dose modified.

StRs and CT doctors in haematology. September Folinic acid dose modified. High dose Methotrexate and folinic acid rescue Full Title of Guideline: Author (include email and role): Division & Speciality: Clinical Guideline Review Date September 2018 GUIDELINE FOR THE USE OF HIGH

More information

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests

Characteristics of factor x so that its clearance = GFR. Such factors that meet these criteria. Renal Tests. Renal Tests Renal Tests Holly Kramer MD MPH Associate Professor of Public Health Sciences and Medicine Division of Nephrology and Hypertension Loyola University of Chicago Stritch School of Medicine Renal Tests 1.

More information

Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study

Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study Original article: Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study Mukesh Agarwal Assistant Professor, Department of General Medicine, Teerthanker Mahaveer Medical College & Research

More information

Development of clinical pharmacy services for intensive care units in Korea

Development of clinical pharmacy services for intensive care units in Korea Kim et al. SpringerPlus 2014, 3:34 a SpringerOpen Journal RESEARCH Open Access Development of clinical pharmacy services for intensive care units in Korea Jeong Mee Kim 1,2, So Jin Park 2, You Min Sohn

More information

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2 Journal of Pharmacy and Pharmacology 5 (2017) 607-615 doi: 10.17265/2328-2150/2017.09.001 D DAVID PUBLISHING Comparative Evaluation of Pharmacist-Managed Vancomycin Dosing in a Community Hospital Following

More information

WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT

WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT - Entering orders for anticoagulation in Cerner Providers will enter individual orders (oneoffs)

More information

EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING

EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING Commentary provided by: Julie Hall, MHS, MT (ASCP) Assistant Dean, College of Health Professions Assistant Professor, Medical Laboratory Science Grand Valley

More information

AWARENESS OF DENTISTS ABOUT MEDICATION ERRORS

AWARENESS OF DENTISTS ABOUT MEDICATION ERRORS AWARENESS OF DENTISTS ABOUT MEDICATION ERRORS Sangeetha P 1, Prabhawati P I 2, Inamadar P I 3, HOW TO CITE THIS ARTICLE: Sangeetha P, Prabhawati PI, Inamadar PI,. Awareness of dentists about medication

More information

Drug dosing in Extremes of Weight

Drug dosing in Extremes of Weight Drug dosing in Extremes of Weight The Plump & Heavy versus The Skinny & Light Maria Minerva P. Calimag, MD, MSc, PhD, DPBA, FPSECP PROFESSOR Departments of Pharmacology, Anesthesiology and Clinical Epidemiology

More information